IPORZRA
Rezera Inc. IPO: What Investors Need to Know
Rezera Inc. is expected to list on NASDAQ on 2026-11-12 under the symbol RZRA, with shares priced in a $11.00 to $13.00 range. The company is offering 16,666,667 shares in a clinical-stage biotech IPO built around oral NLRP3 inhibitors. The bull case is a large unmet need in PAD and a pipeline with strategic backers; the bear case is that Rezera has no revenue, no approved product, and a long clinical path ahead.
Nov 6, 20265 MIN